Australia's ReNerve at four-month high on medical product launch

Renerve

22/09/2025 02:30

** Shares of ReNerve RNV.AX rise as much as 18.2% to A$0.48, their highest point since May 12

** Stock posts its biggest intraday pct rise since July 28

** The biotech firm announces launch of its tissue-based medical product range,  Empliq, in the United States

** Adds Empliq was developed with Berkeley Biologics and focuses on a range of indications already targeted by ReNerve

** About 455,189 shares change hands, 3.9 times the 30-day avg

** Stock down 28.6% YTD, including the session's moves

 (Reporting by Anjali Singh in Bengaluru)

 ((anjali.singh2@thomsonreuters.com;))